SpaceX’s first post-IPO lockup expired on Thursday, August 6, releasing roughly 911.5 million insider shares from restriction. The headlines called it a billion-share flood. The structure underneath is more interesting than that, and considerably less dramatic: this was the first of nine scheduled releases, not a single cliff, and the largest single holder in the company cannot sell anything until next summer.
This article is for informational and educational purposes only. It is not financial advice, investment advice, or a recommendation to buy, sell, or hold any security, cryptocurrency, or financial product. Always verify data with official sources before making financial decisions.
Short answer: what unlocked on August 6
Short answer: Approximately 911.5 million shares held by SpaceX employees, early investors and other insiders became eligible to trade on August 6, 2026 — a block worth roughly $101 billion at the prices around the unlock. Eligible to trade is not the same as sold. The release expands the tradable float from roughly 639 million shares to about 1.55 billion, but it says nothing about how many holders actually want out, and the company’s largest shareholder is excluded entirely until 2027.
| Item | Figure |
|---|---|
| Shares released August 6 | ~911.5 million |
| Approximate value at unlock | ~$101 billion |
| Float before | ~639 million shares |
| Float after | ~1.55 billion shares |
| Freely tradable by December 8, 2026 | ~40% of shares outstanding |
| Elon Musk lockup length | 366 days — cannot sell until ~June 2027 |
The nine-stage schedule, not a single cliff
Most IPOs use one lockup date. Everything is restricted for 180 days, and then everything is not. That structure concentrates supply into a single session and is precisely why lockup expiries developed their reputation for ugly price action.
SpaceX did not do that. The underwriters wrote a staggered release: tranches of roughly 7% of shares unlocking at days 70, 90, 105, 120 and 135 after listing, with two much larger releases tied to earnings dates. The first big wave — the August 6 event — landed about two trading days after the Q2 report and freed somewhere between 20% and 30% of total shares. A second tranche of roughly 28% follows after the Q3 report. The 180-day mark on December 8 completes the sequence, at which point roughly 40% of all shares outstanding are freely tradable.
The practical effect is that supply arrives in instalments the market can see coming, rather than in one block it has to absorb blind. Whether that is better or worse for the share price depends entirely on whether you think a known, spread-out supply schedule is easier to price than a single dated event. It is not obvious that it is — a staggered structure also means the overhang story does not end, it just recurs.
Why a large share of the insider block stayed locked
The August release did not free every restricted share. Two separate mechanisms held a substantial portion back.
The first is the tranche schedule itself: later stages of the nine-part release simply had not arrived yet. The second is founder-specific. Elon Musk’s holding carries a 366-day lockup rather than the standard period, which removes the single largest block of stock from the tradable pool until roughly June 2027. Any calculation of “shares that could hit the market” that includes founder stock is wrong for another ten months.
This distinction matters more than it sounds. Concentrated founder stakes are usually the thing that actually moves a stock on an unlock, because they are large enough to require a marketed secondary rather than ordinary open-market selling. Excluding that block changes the character of the supply from “one seller who must find a buyer of size” to “many holders making individual decisions.”
Float math: 639 million shares before, up to 1.55 billion after
The float roughly doubled. That is a real change and it has second-order effects that have nothing to do with insider sentiment.
A larger float generally means tighter bid-ask spreads and lower borrow costs, which makes the stock cheaper to short. It also affects index eligibility: most major indices weight by float-adjusted market capitalisation, so a doubling of tradable shares mechanically increases index weight and forces passive funds to buy — a demand-side offset that arrives on rebalance dates rather than on the unlock date itself. For a name of this size, that passive bid is not trivial.
So the unlock adds supply and, on a lag, adds a source of demand. Analysts who model only the first half of that are modelling half the trade.
What a lockup expiry does and does not predict about price
The academic record on lockup expiries is thinner and more mixed than the financial press suggests. The commonly cited finding is a modest negative abnormal return in a window around the expiry, on the order of low single-digit percentages, concentrated in companies with high venture-capital ownership and no accompanying secondary offering.
Three caveats matter. Expiries are known in advance and disclosed in the prospectus, so efficient-markets logic says the effect should already sit in the price — and in many cases the drift shows up in the weeks before the date, not on it. The effect size is small relative to the daily volatility of a newly public growth company. And the sample of megacap IPOs with staggered, earnings-linked release schedules is very small, which means historical averages drawn from conventional single-date lockups may not transfer here at all.
The honest summary: a lockup expiry is a supply event with a weak, well-known and already-priced average effect. It is not a directional signal.
How insiders actually sell: 10b5-1 plans, block trades, secondaries
Eligibility to sell and mechanism of selling are different questions, and the mechanism determines the market impact.
- Rule 10b5-1 plans. Executives adopt these in advance, specifying dates or price triggers, which gives them an affirmative defence against insider-trading claims. Sales under a plan are scheduled and mechanical — they tell you almost nothing about the seller’s current view. Following 2022 amendments, plans carry mandatory cooling-off periods before the first trade.
- Block trades. A large holder sells to an investment bank at a negotiated discount to the last price; the bank distributes the stock. This clears size quickly and off-screen, and the discount is the real cost.
- Registered secondary offerings. The company files, the shares are marketed to institutions, and the deal is priced at a discount. This is the most visible route and the one most likely to produce a headline.
- Ordinary open-market sales. Employees selling modest amounts through a broker. Individually invisible, collectively meaningful.
The first weeks after an unlock are usually dominated by the last category — diversification by people whose entire net worth sits in one stock. That flow is price-insensitive and steady rather than sharp.
Dates still ahead
The August 6 release was the first large one, not the last. A second major tranche of roughly 28% of shares follows after the Q3 earnings report, and the 180-day mark on December 8, 2026 completes the staged schedule with roughly 40% of shares outstanding freely tradable. Musk’s 366-day restriction lapses around June 2027, and by mid-2027 nearly all currently restricted stock is expected to be tradable.
For anyone tracking this, the Q3 earnings date is the one to diarise — it governs the timing of the largest remaining tranche.
Risks, uncertainty, and limits
The share counts and dates here come from company filings and contemporaneous reporting around the August 6 expiry, and tranche percentages have been described in ranges rather than exact figures. Percentages of “total shares” and percentages of “restricted shares” are easy to conflate and are frequently reported interchangeably; check which denominator a given number uses before comparing sources.
Nothing above forecasts a direction. The size of an unlock tells you how many shares can move, not how many will, at what price, or whether the market has already discounted it. Verify the current schedule against the prospectus and the company’s SEC filings before acting on any of it.
